| Title: |
P965: FOLLOW-UP ANALYSIS OF THE RANDOMIZED PHASE II TRIAL OF BORTEZOMIB, LENALIDOMIDE, DEXAMTHASONE WITH/WITHOUT ELOTUZUMAB FOR NEWLY DIAGNOSED, HIGH RISK MULTIPLE MYELOMA (SWOG-1211) |
| Authors: |
Usmani, S.; Hoering, A.; Ailawadhi, S.; Sexton, R.; Lipe, B.; Valent, J.; Rosenzweig, M.; Zonder, J.; Dhodapkar, M.; Callander, N.; Zimmerman, T.; Voorhees, P.; Durie, B.; Rajkumar, S. V.; Richardson, P.; Orlowski, R. |
| Source: |
HemaSphere ; volume 6, page 855-856 ; ISSN 2572-9241 |
| Publisher Information: |
Wiley |
| Publication Year: |
2022 |
| Collection: |
Wiley Online Library (Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1097/01.hs9.0000846728.05693.f8 |
| DOI: |
10.1097/01.HS9.0000846728.05693.f8 |
| Availability: |
https://doi.org/10.1097/01.hs9.0000846728.05693.f8; https://journals.lww.com/10.1097/01.HS9.0000846728.05693.f8 |
| Rights: |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Accession Number: |
edsbas.996C278E |
| Database: |
BASE |